ARK Investment Management LLC Buys 2,521 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

ARK Investment Management LLC grew its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 72.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,989 shares of the company’s stock after acquiring an additional 2,521 shares during the period. ARK Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $141,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its holdings in shares of ARK Genomic Revolution ETF by 31.0% in the third quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after purchasing an additional 698,701 shares during the period. Atom Investors LP raised its position in ARK Genomic Revolution ETF by 15.2% during the 3rd quarter. Atom Investors LP now owns 49,131 shares of the company’s stock valued at $1,258,000 after purchasing an additional 6,496 shares in the last quarter. Barclays PLC lifted its holdings in shares of ARK Genomic Revolution ETF by 252.7% in the 3rd quarter. Barclays PLC now owns 285,108 shares of the company’s stock worth $7,299,000 after buying an additional 204,283 shares during the period. National Bank of Canada FI grew its position in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after buying an additional 920 shares in the last quarter. Finally, Crescent Grove Advisors LLC increased its stake in shares of ARK Genomic Revolution ETF by 5.5% during the fourth quarter. Crescent Grove Advisors LLC now owns 30,509 shares of the company’s stock valued at $718,000 after buying an additional 1,595 shares during the period.

ARK Genomic Revolution ETF Stock Up 8.5 %

ARKG stock opened at $25.63 on Thursday. The company has a fifty day moving average price of $25.90 and a 200-day moving average price of $25.41.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.